not just biomedical research, but specifically diabetes research. it is reasonable for forbid diabetes researchers from discussing their funding issues during a

not just biomedical research, but specifically diabetes research. it is reasonable for forbid diabetes researchers from discussing their funding issues during a conference specifically for them?